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Abstract
Background: Since the approval of medical abortion in Cambodia in 2010, the proportion of women reporting an
abortion has increased. We describe the characteristics and contraceptive outcomes of women seeking medical
abortion compared to surgical abortion at four reproductive health clinics in Cambodia.
Methods: Secondary data analysis using data collected in the MObile Technology for Improved Family Planning
(MOTIF) trial, a single blind, randomized trial of a personalized, mobile phone-based intervention designed to
support post-abortion family planning in Cambodia. Baseline interviews were conducted after women had received
post-abortion family planning counselling at the clinic, and follow-up interviews were conducted at 4 and 12
months. We used multivariable logistic regression to assess associations between abortion type and baseline
characteristics, contraceptive uptake, repeat pregnancy and repeat abortion. We conducted an exploratory analysis
to compare the timing of initiation of long-acting (LA) contraception between women having medical versus
surgical abortion over the four-month post-abortion period.
Results: Of the 500 women who participated in the trial, 41% had a medical abortion. In multivariate analyses,
women undergoing medical abortion were more likely to be urban residents, have a higher level of education, be
undecided or not intending to use family planning, and be undecided or intending to have another child. There
was no association between type of abortion and contraceptive uptake, repeat pregnancy or repeat abortion.
Women who had medical abortion initiated LA contraception post abortion later than women who had surgical
abortion.
Conclusions: Our results suggest women having a medical abortion in Cambodia have different baseline characteristics
and had delayed uptake of contraception compared to women having a surgical abortion. However, we cannot draw
conclusions on the direction of associations and causality. Further research is recommended to explore reasons for the
observed findings with view to increasing access to abortion and post-abortion contraception.
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Introduction
It is estimated that globally around 25% of pregnancies re-
sulted in induced surgical or medical abortion during the
period 2010–2014, equating to an annual abortion rate of
35 per 1000 women aged 15–44. [1] In Cambodia in re-
sponse to high maternal mortality, estimated at 900/
100,000 live births, abortion laws were reformed in 1997
to allow abortion on request until the 12th week of preg-
nancy, and in certain circumstances during the second tri-
mester. [2]. According to the 1997 law, abortions can only
be provided by medical doctors, medical practitioners or
midwives authorized by the Ministry of Health and only
carried out in a hospital, health center, health clinic or ma-
ternity ward. [3] The medical abortion pack ‘Medabon’
containing mifepristone and misoprostol was approved by
the Cambodia Ministry of Health in 2010 and made avail-
able in a restricted number of health facilities and phar-
macies. [2] Medical abortion is available in clinic settings
and from pharmacies and medical abortion packs have
been distributed in Cambodia via social marketing and
franchising programmes by non-governmental organisa-
tions such as Population Services Khmer. [4] Cambodian
women also use other pharmaceutical products to induce
an abortion, purchased from pharmacists, markets and
drug sellers; typically unregistered combinations of mife-
pristone and misoprostol, sometimes described as “Chin-
ese pills” [4, 5].
Sequential demographic and health surveys in
Cambodia indicate that the proportion of women report-
ing having had an induced abortion in the previous 5
years increased from 4% in 2005 to 7% in 2014. [3, 6, 7]
Following the approval of medical abortion in 2010, the
proportion of women having medical rather than surgi-
cal abortion increased: from 31% in 2010 to 47% in
2014. [3, 7]
Women seeking abortion services often have an un-
met need for family planning. Post-abortion family
planning (PAFP) can reduce subsequent unplanned
pregnancies and repeat abortion and was identified as
a high-impact practice in family planning by a USAID
technical advisory group in 2012. [8] Women are at
risk of pregnancy soon after abortion; studies that
have examined return to ovulation post-abortion show
that this can occur around 2–3 weeks following the
abortion, but earlier among some women. [9, 10] All
contraceptive methods are safe to use in the immedi-
ate post-abortion period to reduce the risk of preg-
nancy, with the exception of the intra-uterine device
(IUD), which can be inserted at the time of surgical
abortion but in the case of medical abortion should
be delayed until after the abortion is complete. [11–
13] The type of abortion obtained may therefore
affect uptake of post-abortion contraception or the
contraceptive method chosen.
We describe characteristics and contraceptive out-
comes of women seeking medical abortion vs. surgical
abortion, using data collected in the MObile Technology
for Improved Family Planning (MOTIF) trial. [14] The
specific objectives are to compare: (1) baseline character-
istics amongst women seeking medical versus surgical
abortion in the MOTIF trial; (2) outcomes: contracep-
tion use, repeat pregnancy and abortion amongst women
seeking medical versus surgical abortion in the trial; and
(3) the timing of initiation of long-acting contraception
between women having medical versus surgical abortion
over the four-month post-abortion period.
Methods
We analysed data collected during the MOTIF trial. The
trial protocol, results and process evaluation are reported
in separate manuscripts. [15, 16] In brief, the MOTIF trial
was a single blind, randomized trial of a personalized, mo-
bile phone-based intervention designed to support
post-abortion contraception. Women were recruited by
research assistants from four clinics in Cambodia during
May to September 2013. The clinics in Phnom Penh (2),
Battambang and Siem Reap served clients from urban and
rural areas. On recruitment, women were asked whether
they considered their residence to be urban or rural.
Women were eligible for inclusion if they were aged 18 or
older, attending for an induced abortion at the MSI clinic
(either surgical or medical, using licensed medication),
had a mobile phone primarily for their own use, reported
not wanting to become pregnant and were willing to re-
ceive automated messages about contraception. Baseline
interviews were conducted after women had received
post-abortion family planning counselling at the clinic for
the abortion visit, and follow-up interviews were con-
ducted at 4 and 12months. Follow-up was 86% at 4
months and 66% at 12months. There was no evidence of
differential loss to follow-up between women receiving
medical compared to surgical abortion at four or 12
months. [17]
Analysis
First, factors associated with medical versus surgical
abortion in univariable analyses were identified, based
on a likelihood ratio test (LRT) p-value< 0.1. A multivar-
iable model was obtained from a stepwise model build-
ing process, whereby covariates were added to the
multivariable model in turn, and the goodness of fit of
the model with the additional parameter was compared
to the previous model using a LRT. Covariates were
retained in the multivariable model if the LRT p-value <
0.1. Covariates were removed if not associated with the
outcome after adjustment for other covariates during
this process.
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Secondly, we assessed crude and adjusted associa-
tions between abortion method and effective contra-
ceptive use, repeat pregnancy and abortion at 4 and
12-months using logistic regression. We define effect-
ive modern methods to be those associated with <
10% 12-month pregnancy rates, as commonly used:
Oral Contraceptive (OC), injectable, implant, IUD, or
permanent methods [18]. A participant was consid-
ered to be using an effective method if she reported
that she: (i) was currently using the implant or IUD;
(ii) had received the injectable within the previous 3
months; (iii) was sterilized (or partner was sterilized);
or (iv) had taken an OC within 24 h of the interview
or according to instructions. Long acting methods
were defined as the IUD, implant or a permanent
method. The pre-specified approach was to adjust for
age, socio-economic status and residence a priori, as
well whether the participant was allocated to receive
the intervention or not. Access to motorised transport
was used as a measure of socio-economic status,
similar to the assessment of household wealth in the
Cambodia DHS survey. [3] Age cut offs above and
below 25 were selected to be consistent with MSI
definitions of young women and our previous publica-
tions. [19] All participants who were allocated to the
intervention and could be contacted received the
intervention messages. Those who could not be
Table 1 Characteristics of the study sample
N %
Type of abortion
Medical 207 41
Surgical 293 59
Age group
Age > 25 343 69
Age < 25 157 31
Residence
Rural 321 64
Urban 179 36
Socio-economic status
No access to motorised transport 65 13
Access to motorised transport 435 87
Level of Education
None or primary 196 39
Some secondary or above 304 61
Marital status
Never married or living together 29 6
Married/living together 464 93
Divorced/separated 7 1
# living children
1 or more 353 71
0 147 29
# previous abortions
0 299 60
1 or more 201 40
Previous contraception use
Yes 299 60
No 201 40
Occupation
Housewife 102 20
Factory worker 76 15
Entertainment worker 27 5
Farmer 32 6
Employed 99 20
Self-employed/own business 134 27
Casual work/casual labour 3 1
Student 17 3
Unemployed 9 2
vOther 1 0
Contraception decision-makinga
Mainly woman 96 21
Mainly husband/partner 78 17
Joint decision 290 63
Phone sharing
Table 1 Characteristics of the study sample (Continued)
N %
Shares 241 48
Never shares 259 52
Disclosure of abortion to othersb
Yes 204 85
No 37 15
PAFP intentions
Yes 187 37
No 42 8
Undecided 271 54
Fertility plans
No more/none 139 28
Have a/another child 308 62
Undecided 53 11
Phone credit
Sometimes 193 39
Usually 128 26
Always 179 36
Randomisation
Intervention 249 50
Control 251 50
a36 missing values b259 missing values
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Table 2 Associations with type of abortion
Surgical Medical Crude OR LRT p value Adjusted ORa LRT p value
N = 293 N = 207
Age group
Age > 25 213 (62%) 130 (38%) 1.00
Age < 25 80 (51%) 77 (49%) 1.58 (1.08–2.31) 0.019
Residence
Rural 216 (67%) 105 (33%) 1.00
Urban 77 (43%) 102 (57%) 2.73 (1.87–3.97) < 0.001 2.18 (1.46–3.25) < 0.001
Socio-economic status
No access to motorised transport 45 (69%) 20 (31%) 1.00
Access to motorised transport 248 (57%) 187 (43%) 1.70 (0.97–2.97) 0.058
Level of Education
None or primary 130 (66%) 66 (34%) 1.00
Some secondary or above 163 (54%) 141 (46%) 1.70 (1.17–2.47) 0.005 1.45 (0.97–2.17) 0.068
Marital status
Never married or living together 18 (62%) 11 (38%) 1.00
Married/living together 271 (58%) 193 (42%) 1.17 (0.54–2.52) 0.924
Divorced/separated 4 (57%) 3 (43%) 1.23 (0.23–6.55)
# living children
1 or more 223 (63%) 130 (37%) 1.00
0 70 (48%) 77 (52%) 1.89 (1.28–2.78) 0.001
# previous abortions
0 171 (57%) 128 (43%) 1.00
1 or more 122 (61%) 79 (39%) 0.87 (0.60–1.25) 0.435
Previous contraception use
Yes 180 (60%) 119 (40%) 1.00
No 113 (56%) 88 (44%) 1.18 (0.82–1.69) 0.376
Occupation
Housewife 67 (66%) 35 (34%) 1.00
Factory worker 35 (46%) 41 (54%) 2.24 (1.22–4.12) < 0.001
Entertainment worker 15 (56%) 12 (44%) 1.53 (0.65–3.63)
Farmer 29 (91%) 3 (9%) 0.20 (0.06–0.70)
Employed 57 (58%) 42 (42%) 1.41 (0.80–2.50)
Self-employed/own business 78 (58%) 56 (42%) 1.37 (0.81–2.34)
Casual work/casual labour 2 (67%) 1 (33%) 0.96 (0.08–10.93)
Student 5 (29%) 12 (71%) 4.59 (1.50–14.09)
Unemployed 4 (44%) 5 (56%) 2.39 (0.60–9.48)
Other 1 (100%) 0 (0%) 1.00 (.-.)
Contraception decision-making
Mainly woman 71 (74%) 25 (26%) 1.00
Mainly husband/partner 47 (60%) 31 (40%) 1.87 (0.98–3.56) 0.001
Joint decision 154 (53%) 136 (47%) 2.51 (1.50–4.18)
Phone sharing
Shares 142 (59%) 99 (41%) 1.00
Never shares 151 (58%) 108 (42%) 1.03 (0.72–1.46) 0.888
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contacted were considered lost to follow up and ex-
cluded from the analyses on contraceptive use, repeat
pregnancy and repeat abortion.
Thirdly, we conducted an exploratory analysis to com-
pare the timing of initiation of long-acting contraception
between women having medical versus surgical abortion
over the four-month post-abortion period. This analysis
used data on weekly contraceptive use was obtained
retrospectively at four-month follow-up.
Ethical approval for the MOTIF study was obtained
from ethics committees at the London School of Hy-
giene and Tropical Medicine and Marie Stopes Inter-
national and from the Cambodia Human Research
ethics committee. All analyses were conducted using
Stata, Version 15.
Results
Of the 500 women who participated in the trial 41% had a
medical abortion. Over two thirds of the sample were aged
over 25, almost two thirds lived in rural areas, and the ma-
jority had access to motorized transport. Almost two thirds
had secondary level education or above, and nearly all were
married or living together. The full description of the sam-
ple is shown in Table 1. Table 2 shows the characteristics of
women attending for medical versus surgical abortion. Uni-
variable analyses suggested that younger age (p = 0.019),
urban versus rural area of residence (p < 0.001), access to
motorized transport (p = 0.058), higher level of education
(p = 0.005), having no living children (p = 0.001), having
mainly joint or mainly partner decision-making about
contraception (p = 0.001), not intending or undecided about
PAFP (p < 0.001), plans to have another child or undecided
about more children (p < 0.001), were associated with in-
creased odds of medical versus surgical abortion. Occupa-
tion was associated with type of abortion (p < 0.001).
During development of a final multivariable model, age was
included first, then factors identified in univariable analyses
were added and evaluated for association with abortion type
after adjustment in turn, first looking at socio-economic fac-
tors and then fertility and contraceptive related factors. The
final model included level of education, PAPF intentions,
fertility plans and area of residence. Age and number of
children were no longer associated with type of abortion
after adjustment for contraceptive and fertility plans. After
adjustment for factors included in the final model, medical
versus surgical abortion was more likely amongst those with
more education, those without plans for or undecided about
PAFP, those undecided or desiring a child in future and
those living in urban areas. Whether contraceptive decisions
were mainly made by a husband/partner or made jointly
was only asked to those who were currently married. Of this
group of 464 women, joint or partner contraceptive decision
making was not strongly associated with type of abortion
after adjustment for other factors in the final model for all
women (p = 0.085). After adjustment for the other variables
in the final model, occupation was not associated with abor-
tion type (LRT p = 0.289).
Table 3 shows associations between abortion method
and subsequent contraceptive use, repeat pregnancy and
repeat abortion. Surgical abortion was associated with
increased odds of using effective contraception at 4
months compared to medical abortion but this
Table 2 Associations with type of abortion (Continued)
Surgical Medical Crude OR LRT p value Adjusted ORa LRT p value
N = 293 N = 207
Disclosure of abortion to others
Yes 122 (60%) 82 (40%) 1.00
No 20 (54%) 17 (46%) 1.26 (0.63–2.56) 0.515
PAFP intentions
Yes 135 (72%) 52 (28%) 1.00
No 22 (52%) 20 (48%) 2.36 (1.19–4.68) < 0.001 2.08 (1.02–4.23) 0.001
Undecided 136 (50%) 135 (50%) 2.58 (1.73–3.84) 2.18 (1.44–3.31)
Fertility plans
No more/none 105 (76%) 34 (24%) 1.00
Have a/another child 162 (53%) 146 (47%) 2.78 (1.78–4.35) < 0.001 2.07 (1.29–3.32) 0.007
Undecided 26 (49%) 27 (51%) 3.21 (1.65–6.22) 2.08 (1.03–4.18)
Phone credit
Sometimes 123 (64%) 70 (36%) 1.00
Usually 67 (52%) 61 (48%) 1.60 (1.02–2.52) 0.120
Always 103 (58%) 76 (42%) 1.30 (0.85–1.97)
aAdjusted for factors included in the final model
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association did not remain after adjusting for confound-
ing variables (aOR 1.44; 95%CI 0.95–2.18). There were
no statistically significant differences in contraceptive
use, repeat pregnancy or repeat abortion comparing
women having medical versus surgical abortion, but it is
acknowledged that power was low for these analyses.
Figure 1 shows the timing of initiation of long-acting
contraception over the four-month post-abortion period.
Women having surgical abortion appear more likely to
initiate long-acting contraception sooner compared to
women having medical abortion; 50 women reported ini-
tiating long-acting contraceptive after surgical abortion,
of whom 34 (68%) started during the first week. 29
women reported initiating long-acting contraception use
after medical abortion, of whom nine (31%) started dur-
ing the first week (p = 0.001). Of the 34 women who had
a surgical abortion and started using long-acting contra-
ception during the first week, 14 (41%) started using an
IUD and 20 started using the implant. Of the nine
women who had a medical abortion and started using
long-acting contraception during the first week, two
(22%) started using an IUD and seven started using the
implant.
Discussion
Summary of main results
In this observational study using randomized controlled
trial data, women having a medical abortion were more
likely than those having a surgical abortion to be of
urban residence, more educated, not planning to use or
undecided about PAFP, and be planning to have another
child or undecided. There was no association between
type of abortion (medical vs. surgical) and use of effect-
ive contraception at 4 months, repeat pregnancy, or re-
peat abortion. Initiation of long-acting contraception
within the first week was less likely with medical than
surgical abortion.
Strengths and weaknesses
To our knowledge, this is the first quantitative study
reporting differences in characteristics of medical ver-
sus surgical abortion clients attending
non-governmental health facilities in Cambodia, and
complements trends in medical abortion use observed
in the Demographic and Health Survey and previous
qualitative studies in Cambodia and neighbouring
Vietnam. [2, 5, 20] The study benefits from a sample
size of 500 and a follow-up period of 12 months with
good follow-up rates.
A key limitation of the study is the potential for re-
sidual and unmeasured confounding. It would have been
particularly useful to have data on pregnancy duration.
The 2014 Cambodian Demographic and Health Survey
reported that use of surgical abortion increased with age
and pregnancy duration [3, 7]. We also do not have in-
formation on provider behaviors – it is possible that
providers may show bias in the type of abortion that
they offer or recommend. Furthermore, we cannot draw
Table 3 Associations between abortion method and subsequent contraception use, repeat pregnancy and abortion
Four month follow-up 12month follow-up
No Yes Crude OR P
value
Adjusted OR* P
value
No Yes Crude OR P
value
Adjusted OR* P
value
Effective contraception use
Medical 93 (52%) 85 (48%) 1.00 75 (54%) 63 (46%) 1.00
Surgical
102
(40%)
151
(60%)
1.62
(1.10–2.38)
0.015 1.44 (0.95–2.18) 0.084 101 (53%) 89 (47%) 1.05
(0.68–1.63)
0.831 0.87 (0.55–1.39) 0.563
Long-acting contraception use
Medical 146
(82%)
32 (18%) 1.00 113 (82%) 25 (18%) 1.00
Surgical
205
(81%)
48 (19%) 1.07
(0.65–1.75)
0.794 0.87 (0.51–1.49) 0.611 154 (81%) 36 (19%) 1.06
(0.60–1.86)
0.848 0.84 (0.46–1.54) 0.573
Repeat pregnancy
Medical 171
(97%)
6 (3%) 1.00 116 (84%) 22 (16%) 1.00
Surgical
248
(98%)
5 (2%) 0.57
(0.17–1.91)
0.367 0.82 (0.23–2.86) 0.750 162 (85%) 28 (15%) 0.91
(0.50–1.67)
0.764 0.97 (0.51–1.84) 0.924
Repeat abortion
Medical 176
(99%)
1 (1%) 1.00 127 (92%) 11 (8%) 1.00
Surgical
251
(99%)
2 (1%) 1.40
(0.13–15.59)
0.783 2.04 (0.17–24.22) 0.572 182 (96%) 8 (4%) 0.51
(0.20–1.30)
0.157 0.50 (0.19–1.35) 0.172
*Adjusted for age, residence, socio-economic status and whether randomised
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conclusions on the direction of associations and
causality.
A further limitation concerns the generalizability of the
findings. These results reflect the NGO clinic population
and may be different in public and private health facilities,
and among women obtaining medical abortion from phar-
macies. However, the proportions obtaining medical abor-
tion are similar to 2013 data from MSI Cambodia. [14] In
addition, the sample was restricted to women who had ac-
cess to a mobile phone, although in Cambodia over 90%
of women are estimated to own a mobile phone [21]. Fu-
ture research should examine the needs of women using
MA outside of the formal heath sector (e.g. from drug
sellers) in terms of follow-up and PAFP. Further qualita-
tive research could also consider how fertility intentions
and provider biases might influence both the type of abor-
tion that a woman has and subsequent use of PAFP.
Finally, the study was underpowered to examine differ-
ences in contraceptive and reproductive outcomes
between women having medical and surgical abortions –
although we found no evidence of a difference in PAFP
uptake, repeat pregnancy or repeat abortion in this sam-
ple, a larger study may do.
Discussion of the findings in context of existing research
Previous research has shown that a wide range of socio
demographic variables as well as knowledge of abortion
methods influence the uptake of medical abortion rather
than surgical abortion. Our finding that rural women
were less likely to choose MA are consistent with find-
ings from Ethiopia, India, and Nepal but not Vietnam
[22–25]. Our finding that educated women were more
likely to use MA are in keeping with study findings in
the USA and Nepal, but studies in Ethiopia and Vietnam
did not find such an association [24–26]. To our know-
ledge no previous studies have reported the association
between choice of MA and uncertainty about future
contraceptive and fertility plans.
Access to a clinic is a barrier to obtaining abortion ser-
vices and poor geographic access has been shown to be
a barrier to women seeking other maternal health ser-
vices in rural areas of Cambodia [27, 28]. Our finding
that women living in rural areas are more likely to opt
for surgical abortion rather than medical abortion could
be due to the distance to clinic and the desire for greater
certainty about the abortion being complete at the time
of the clinic visit. It may also be that greater difficulties
in access result in rural women attending later for med-
ical abortion.
In this setting, women were offered a follow-up visit to
check for post-abortion complications or a continuing
pregnancy after both medical and surgical abortion as
per national guidelines, [13] although routine data show
that many women do not attend. [29] MSI Cambodia
Fig. 1 Initiation of long-acting contraception (IUD or implant) over 4-month post-abortion period *data obtained retrospectively at 4months
asking participants about weekly contraceptive use. 50 women reported initiating long-acting contraceptive after surgical abortion, of whom 34
(68%) started during the first week. 29 women reported initiating long-acting contraception use after medical abortion, of whom 9 (31%) started
during the first week
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reports a 97.3% success rate for medical abortion.
Self-assessment of the outcome of medical abortion is
accurate, feasible and safe in low-resource settings. [30,
31] Enabling women to self-manage follow-up, as rec-
ommended in the WHO guidelines, [32] is likely to re-
duce barriers to medical abortion in urban and rural
low-resource settings. [33].
Women with more education might be more confident
in using medical abortion as it might be easier for them
to read any written instructions provided and contact
the clinic in case of a problem.
The associations between abortion type and contra-
ception and fertility intentions could be explained by
concerns about future fertility. Women who were un-
decided or planning on having more children (i.e. birth
spacers rather than limiters) may have a preference for
medical abortion if surgical abortion or contraception
use is perceived as more harmful, potentially affecting
the uterus and impacting fertility. [4]
Women undergoing medical abortion were no less
likely than those undergoing surgical abortion to obtain
post-abortion family planning (PAFP), including
long-acting reversible contraception (LARC). All partici-
pants received standard care at the clinic prior to
randomization, which included contraceptive counselling
and the choice of a range of methods (e.g. pill, injectable
and implant), all of which could be obtained on the day.
It is unsurprising that women obtaining MA have lower
uptake of IUD than women having surgical abortion as
women could have an IUD inserted during surgical pro-
cedure, while women undergoing medical abortion have
to attend and appointment for fitting 2 weeks later. It is
perhaps surprising that women undergoing surgical
abortion were not more likely to use LARC given the
convenience of IUD insertion during the procedure, ver-
sus a repeat visit following medical abortion. However,
LARC use is relatively low in Cambodia; roughly 2% of
married women use the implant and 4% use the IUD
compared to 9% who use the injectable, and 18% who
use the contraceptive pill [3]. In contexts with a different
baseline method mix, there might be greater differences
in uptake of LARC between those undergoing medical
and surgical abortion.
The findings did show that among women who started
LARC methods post-abortion, women who obtained a
medical abortion had a more delayed initiation. This may
reflect the delay required between the procedure and the
insertion of an IUD following medical abortion. This is sup-
ported by the finding that, among those who started LARC
in the first week, the proportion starting to use an IUD (ra-
ther than implant) was higher among women who had a
surgical abortion. Additionally, women having a medical
abortion may have wished to have confirmation that the
abortion was complete before starting to use the implant.
Conclusion
Our results suggest women having a medical abortion in
Cambodia are more likely to be educated and live in urban
areas and had delayed uptake of contraception compared
to women having a surgical abortion, although there was
not strong evidence for a difference in contraceptive use
at four or 12month follow up. Our findings suggest there
is a continuing need to improve access to abortion ser-
vices, particularly in rural areas, as well as to take into ac-
count the factors influencing women’s choice of abortion
method during the consultation. They also raise questions
about whether routine follow-up is required after abor-
tion. Enabling self-management of medical abortion fol-
low up may increase women’s choice around the
procedure by enabling women who would prefer medical
abortion but cannot because of loss of earnings or dis-
tance barriers to do so Further research is recommended
to increase access to abortion and post-abortion
contraception.
Acknowledgements
We thank all clients and clinic staff who participated in the study; Channe
Suy at the InSTEDD iLab South East Asia; and Uk Vannak, Ly Sokhey, Sieklot
Chinn, Melissa Cockcroft, Nicky Jurgens, Michelle Phillips, Sras Thorng,
Stefanie Wallach and Amy Williamson at Marie Stopes International.
Funding
The Marie Stopes International Innovation Fund funded the study for 15
months from October 2012 and had some influence on the study design
but not on data collection or analysis. The UK Medical Research Council
(MRC) funded the data analysis but had no influence on the analysis or
reporting. Chris Smith was supported by an MRC Population Scientist
Fellowship, grant reference MR/L012251/1 (April 2014 to September 2018).
Availability of data and materials
Data are from the MOTIF study whose authors may be contacted at the
London School of Hygiene and Tropical Medicine, Keppel Street, London,
WC1E7HT. Email: christopher.smith@lshtm.ac.uk.
Authors’ contributions
CS conceived of the current study, CS, RS and TE analysed and interpreted
the data. CS and RS wrote successive drafts. CF commented on some of the
drafts. All authors reviewed, contributed to and approved the final version
for publication.
Ethics approval and consent to participate
Participants provided consent by written signature or thumbprint. Ethical
approval was obtained from ethics committees at the London School of
Hygiene & Tropical Medicine and Marie Stopes International and the
Cambodia Human Research ethics committee. The trial was registered
through ClinicalTrials.gov with the identifier NCT01823861.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Graduate School of Tropical Medicine and Global Health, Nagasaki
University, Nagasaki, Japan. 2Department of Population Health, London
Smith et al. Contraception and Reproductive Medicine             (2019) 4:5 Page 8 of 9
School of Hygiene & Tropical Medicine, London, UK. 3MRC Tropical
Epidemiology Group, London School of Hygiene & Tropical Medicine,
London, UK.
Received: 25 July 2018 Accepted: 24 April 2019
References
1. Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies
worldwide in 2012 and recent trends. Stud Fam Plan. 2014;45:301–14.
https://doi.org/10.1111/j.1728-4465.2014.00393.x.
2. Petitet PH, Ith L, Cockroft M, Delvaux T. Towards safe abortion access: an
exploratory study of medical abortion in Cambodia. Reprod Health Matters.
2015;22:47–55. https://doi.org/10.1016/S0968-8080(14)43826-6.
3. National Institute of Statistics: Directorate General for Health and ICF
International. Cambodia Demographic and Health Survey 2014 [Internet].
2015. Available from: https://dhsprogram.com/pubs/pdf/FR312/FR312.pdf.
4. Hemmings J, Rolfe B. Abortion in cambodia [Internet]. Options; 2008.
Available from: www.options.co.uk.
5. Petitet P, Desclaux A. Reproductive health and HIV in Cambodia: from
anthropology to public health. Aix Marseille III (France): Groupe de
Recherche cultures, Santé, Sociétés, Paul Cézanne Université; 2011.
6. National Institute of Public Health: National Institute of Statistics and ORC Macro.
Cambodia Demographic and Health Survey 2005. 2006;487. Available from:
https://dhsprogram.com/pubs/pdf/FR185/FR185%5BApril-27-2011%5D.pdf.
7. National Institute of Statistics: Directorate General for Health and ORC
Macro. Cambodia Demographic and Health Survey 2010 [Internet]. 2010.
Available from: http://www.measuredhs.com/pubs/pdf/FR249/FR249.pdf.
8. USAID. High Impact Practices in Family Planning (HIP). Postabortion family
planning: strengthening the family planning component of postabortion
care. Washington DC: USAID; 2012.
9. Stoddard A, Eisenberg DL. Controversies in family planning : timing of
ovulation after abortion and the conundrum of postabortion intrauterine
device insertion. Contraception. 2011;84:119–21. https://doi.org/10.1016/j.
contraception.2010.12.010.
10. USAID. Post-Abortion family planning: a key component of Post abortion
care. 2013.
11. World Health Organization. Medical eligibility criteria for contraceptive use;
2015. https://doi.org/10.2165/00128413-200112870-00010.
12. Cameron S. Postabortal and postpartum contraception. Best Pract Res
Clin Obstet Gynaecol. 2014;28:871–80. https://doi.org/10.1016/j.bpobgyn.
2014.05.007.
13. Cambodia Ministry of Health. National Protocol Cambodia: comprehensive
abortion care 2010.
14. Smith C, Ngo T, Gold J, Edwards P, Vannak U, Sokhey L, et al. Effect of a
mobile phone-based intervention on post-abortion contraception: a
randomized controlled trial in Cambodia. Bull World Health Organ. 2015;93:
842–50. https://doi.org/10.2471/BLT.15.160267.
15. Smith C, Ly S, Uk V, Edwards P, Warnock R, Free C. Process evaluation of a
mobile phone based intervention to support post-abortion contraception in
Cambodia. Contracept Reprod Med. 2017;16. https://doi.org/10.1186/
s12978-017-0329-y.
16. Smith C, Vannak U, Sokhey L, Ngo TD, Gold J, Khut K, et al. MObile
Technology for Improved Family Planning services (MOTIF): study protocol
for a randomised controlled trial. Trials. 2013;14(427):1–9.
17. Smith C, Jarvis C, Free C. Assessing loss to follow-up in the MObile
Technology for Improved Family Planning (MOTIF) randomised controlled
trial. Trials. 2017;18:577. https://doi.org/10.1186/s13063-017-2316-6.
18. World Health Organization. Family planning: a global handbook for
providers. 2011.
19. Maries Stopes International. Young people [Internet]. Available from: https://
mariestopes.org/who-we-serve/young-people/. [cited 2019 Jan 15].
20. Ngo TD, Free C, Le HT, Edwards P, Pham KHT, Nguyen YBT, et al. Women’s
perspectives on termination service delivery in Vietnam: a cross-sectional
survey in three provinces. Int J Women's Health. 2014;6:927–33. https://doi.
org/10.2147/IJWH.S72343.
21. Kimchhoy P, Sola J. Mobile Phones in Cambodia 2014 [Internet]. 2014. Available
from: https://asiafoundation.org/resources/pdfs/MobilephonesinCB.pdf.
22. Tamang A, Tuladhar S, Tamang J, Ganatra B, Dulal B. Factors associated with
choice of medical or surgical abortion among women in Nepal. Int J
Gynecol Obstet. 2012;118:52–6. https://doi.org/10.1016/j.ijgo.2012.05.011.
23. Das V. Evaluation of newer methods of early pregnancy termination. J Obs
Gynecol India. 2005;55:454–6.
24. Woldetsadik MA, Sendekie TY, White MT, Zegeye DT. Client preferences and
acceptability for medical abortion and MVA as early pregnancy termination
method in Northwest Ethiopia. Reprod Health. 2011;9:4–8.
25. Ngo TD, Free C, Le HT, Edwards P, Pham KHT, Nguyen YBT, et al. Service
users’ attributes associated with the uptake of medical versus surgical
abortion at public health facilities in Vietnam. Int J Gynecol Obstet. 2014;
125:247–52.
26. Clark S. Is medical abortion acceptable to all American women: the impact
of sociodemographic characteristics on the acceptability of mifepristone-
misoprostol abortion. J Am Med Womens Assoc. 2012;5:177–82.
27. Matsuoka S, Aiga H, Chan L, Rathavy T, Okitsu A. Perceived barriers to
utilization of maternal health services in rural Cambodia. Health Policy. 2010;
95:255–63. https://doi.org/10.1016/j.healthpol.2009.12.011.
28. Yanagisawa S, Oum S, Wakai S. Determinants of skilled birth attendance in
rural Cambodia. Trop Med Int Heal. 2006;11:238–51. https://doi.org/10.1111/
j.1365-3156.2005.01547.x.
29. Smith C, Vannak U, Sokhey L, Ngo TD, Gold J, Free C. Mobile Technology for
Improved Family Planning (MOTIF): the development of a mobile phone-
based (mHealth) intervention to support post-abortion family planning
(PAFP) in Cambodia. Reprod Health. 2016;13:1–8. https://doi.org/10.1186/
s12978-015-0112-x.
30. Blum J, Sheldon WR, Ngoc NTN, Winikoff B, Nga NTB, Martin R, et al.
Randomized trial assessing home use of two pregnancy tests for
determining early medical abortion outcomes at 3, 7 and 14 days after
mifepristone. Contraception. 2016;94(2):115–21. https://doi.org/10.1016/j.
contraception.2016.04.001.
31. Iyengar K, Paul M, Iyengar SD, Klingberg-Allvin M, Essén B, Bring J, et al. Self-
assessment of the outcome of early medical abortion versus clinic follow-up
in India: a randomised, controlled, non-inferiority trial. Lancet Glob Heal.
2015;3:e537–45. https://doi.org/10.1016/S2214-109X(15)00150-3.
32. WHO. Clinical practice handbook for safe abortion. 2014.
33. Sheldon WR. Home use of urine pregnancy tests for medical abortion
follow-up. Lancet Glob Heal. 2015;3:e504–5. https://doi.org/10.1016/S2214-
109X(15)00153-9.
Smith et al. Contraception and Reproductive Medicine             (2019) 4:5 Page 9 of 9
